VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RVP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RVPRetractable Technologies, Inc.
$0.70$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRVPBalance Sheet

Retractable Technologies, Inc. (RVP) Balance Sheet

26Y historyFree accessUpdated daily

The firm's financial position is deteriorating, with total assets contracting from $179.7M in 2023Q4 to $137.6M in 2026Q1, while retained earnings have eroded to $9.6M over the same period.

RVP Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Total Current Assets59.96M63.08M73.27M77.65M88.81M104.51M69.48M28.41M23.85M26.61M26.68M30.81M34.23M37.91M35.44M35.75M40.22M39.26M43.61M51.92M57.78M61.49M65.05M13.5M7.07M6.27M8.06M
Cash & Short-Term Investments35.62M36.97M44.56M47.29M49.38M42.43M25.65M13.71M10.64M14.88M16.2M18.05M22.13M27.63M25.96M25.67M23.27M18.13M33.28M40.51M46.81M52.51M55.87M8.16M1.34M1.22M3.73M
Cash Only2.77M2.59M4.24M12.67M19.72M29.16M17.57M5.93M9.65M14.88M16.2M18.05M22.13M27.63M25.96M25.67M23.27M18.13M33.28M40.51M46.81M52.51M55.87M8.16M1.34M1.22M3.73M
Short-Term Investments32.85M34.38M40.33M34.62M29.66M13.27M8.08M7.77M996.23K000000000000000000
Accounts Receivable7.29M8.21M8.77M11.83M17.48M40.78M32.91M6.61M5.01M5.11M3.27M4.9M5.64M3.48M3.7M3.62M7.59M13.6M3.29M4.01M4.31M3.97M3.21M1.17M2.67M1.59M2.33M
Days Sales Outstanding81.9178.3396.8199.0267.2979.02146.7457.7654.9954.0239.9960.5359.6641.2240.1841.1176.53127.3843.0355.7162.1659.7354.522.3947.9135.8388.03
Inventory16.43M17.19M19.19M17.58M20.68M20.59M10.23M7.45M7.55M6.21M7.02M6.3M4.66M5.74M4.99M6.24M8.68M6.91M6.64M7.04M6.39M3.3M3.78M3.98M2.78M3.22M1.58M
Days Inventory Outstanding183.26164.15205.54186.06113.4280.7883.2898.32119.4692.38131.45121.0475.66102.2581.07107.39133.0799123.22140.36131.178.0284.0599.0567.6888.1873.01
Other Current Assets622.43K711.27K753.06K952.67K1.26M701.97K684.32K635.2K644.8K418.15K192.55K1.57M1.79M1.07M783.76K218.53K681.24K624.39K400.11K358.81K267.71K1.71M2.18M194.31K276.52K245.56K426.76K
Total Non-Current Assets77.64M79.55M87.45M102.02M121.93M108.65M35.49M17.43M12.95M11.55M12.1M11.73M11.12M11.19M12.19M13.02M12.97M14.68M14.92M12.41M13.01M12.27M11.45M10.13M10.99M12.27M12.43M
Property, Plant & Equipment77.31M79.18M87.35M93.48M100.15M87.93M30.82M10.71M10.85M11.35M12.09M11.47M10.85M10.91M11.9M12.65M12.56M14.23M14.44M11.48M12.21M11.93M11.06M9.68M10.52M11.74M11.9M
Fixed Asset Turnover0.46x0.48x0.38x0.47x0.95x2.14x2.66x3.90x3.07x3.04x2.47x2.58x3.18x2.82x2.83x2.54x2.88x2.74x1.93x2.29x2.07x2.03x1.95x1.97x1.93x1.38x0.81x
Goodwill000000000000000000000000000
Intangible Assets00000000000257.18K265.77K275.04K286.52K362.98K406.91K426.68K470.12K424.56K279.85K316.93K358.66K394.37K405.64K530.38K529.8K
Long-Term Investments000000050.39K1.99M000000000000-1.25B-1.89M0000
Other Non-Current Assets330.94K366.91K103.63K152.06K184.52K5.67K44.57K5.96K103.68K194.51K10.29K4.92K4.92K4.92K4.92K0018.75K18.75K505.9K522.29K27.33K34.01K60.56K72.67K00
Total Assets137.6M142.63M160.72M179.67M210.74M213.15M104.97M45.84M36.79M38.16M38.78M42.54M45.35M49.1M47.63M48.76M53.19M53.94M58.54M64.33M70.79M73.76M76.49M23.63M18.06M18.54M20.49M
Asset Turnover0.26x0.27x0.21x0.24x0.45x0.88x0.78x0.91x0.90x0.90x0.77x0.69x0.76x0.63x0.71x0.66x0.68x0.72x0.48x0.41x0.36x0.33x0.28x0.81x1.13x0.87x0.47x
Asset Growth %-34.8%-11.26%-10.55%-14.74%-1.13%103.06%129.02%24.58%-3.57%-1.61%-8.84%-6.2%-7.63%3.08%-2.32%-8.33%-1.39%-7.85%-9%-9.13%-4.01%-3.58%223.71%30.85%-2.6%-9.51%-
Total Current Liabilities10.45M9.6M8.78M9.38M12.14M35.32M27.9M8.26M8.54M7.9M7.17M8.1M15.1M16.62M8.08M5.97M9.99M13.2M10.24M8.79M6.89M5.46M7.85M5.77M8.02M8.8M5.94M
Accounts Payable5.38M5.34M4.29M4.78M6.4M20.4M16.26M5.01M5.37M4.96M4.47M5.7M5.14M5.11M5.1M3.66M3.85M7M6.14M5.54M4.25M2.35M3.4M3.76M4.23M3.92M1.87M
Days Payables Outstanding47.655145.9650.5835.1280.06132.2966.0885.0273.7983.77109.5383.4391.0582.8562.9958.98100.29114110.487.2155.4975.6793.53102.98107.3386.57
Short-Term Debt481.93K365.28K332.48K303.99K1.38M1.39M1.03M343.3K406.36K410.95K430.39K249.35K149.74K247.06K315.09K620.47K519.61K2.63M451.87K387.91K261.9K295.42K271.84K210.68K840.9K686.4K971.68K
Deferred Revenue (Current)2.37M352.64K376.56K201.49K435.92K2.34M1.69M998.6K860.93K355.74K692.92K395.4K435.82K1.72M1.4M780.5K0001.44M961.28K0945.71K1.54M1.08M1.68M1.16M
Other Current Liabilities3.26M762.21K1.07M865.11K2.85M5.18M826.76K1.28M540.85K1.62M1.72M1.38M9.09M10.19M1.59M1.03M4.86M3.01M2.99M2.3M1.86M2.43M2.04M265.47K1.87M2.52M1.94M
Current Ratio5.74x6.57x8.34x8.28x7.32x2.96x2.49x3.44x2.79x3.37x3.72x3.81x2.27x2.28x4.39x5.99x4.03x2.98x4.26x5.91x8.39x11.26x8.28x2.34x0.88x0.71x1.36x
Quick Ratio4.17x4.78x6.16x6.41x5.61x2.38x2.12x2.54x1.91x2.58x2.74x3.03x1.96x1.94x3.77x4.94x3.16x2.45x3.61x5.11x7.46x10.66x7.80x1.65x0.53x0.35x1.09x
Cash Conversion Cycle217.53191.49256.39234.5145.5979.7597.749089.4472.6187.6772.0551.8852.4138.485.51150.62126.0952.2585.66106.0582.2662.8927.912.6116.6974.46
Total Non-Current Liabilities57.06M58.66M64.77M71.01M92.07M78.66M27.19M9.04M2.64M3.08M3.5M3.42M3.43M3.58M3.83M4.14M4.3M4.82M6.1M3.78M4.19M5.06M4.98M2.72M2.6M9.58M7.18M
Long-Term Debt434.12K530.37K900.04K1.23M1.53M2.85M2.71M2.38M2.64M3.08M3.5M3.42M3.43M3.58M3.83M4.14M4.3M4.82M6.1M3.75M4.14M4.35M3.54M2.72M2.6M9.58M7.18M
Capital Lease Obligations000000000000000000000000000
Deferred Tax Liabilities000015.08M6.85M2.19M6.66M7.43M000000000036.2K45.7M711.44M1.44M0000
Other Non-Current Liabilities56.62M58.13M63.87M69.77M75.46M68.96M24.48M082.36K000000000000000000
Total Liabilities67.5M68.26M73.55M80.38M104.21M113.98M55.09M17.29M11.18M10.98M10.67M11.51M18.52M20.2M11.9M10.11M14.29M18.02M16.33M12.57M11.08M10.52M12.83M8.5M10.62M18.38M13.12M
Total Debt916.05K895.64K1.23M1.54M2.92M4.24M3.74M2.72M3.05M3.49M3.93M3.67M3.57M3.82M4.14M4.76M4.82M7.45M6.55M4.14M4.4M4.65M3.81M2.93M3.44M10.27M8.15M
Net Debt-1.85M-1.69M-3M-11.13M-16.8M-24.92M-13.83M-3.21M-6.6M-11.39M-12.27M-14.38M-18.55M-23.81M-21.82M-20.91M-18.44M-10.67M-26.74M-36.37M-42.42M-47.87M-52.06M-5.22M2.1M9.05M4.42M
Debt / Equity0.01x0.01x0.01x0.02x0.03x0.04x0.08x0.10x0.12x0.13x0.14x0.12x0.13x0.13x0.12x0.12x0.12x0.21x0.16x0.08x0.07x0.07x0.06x0.19x0.46x63.12x1.11x
Debt / EBITDA-0.06x---0.78x0.06x0.15x0.71x-------------------
Net Debt / EBITDA0.12x----4.48x-0.34x-0.56x-0.84x-------------------
Interest Coverage-96.15x-230.03x-27.74x-57.60x31.25x330.91x101.18x19.91x-6.64x-17.62x-16.32x20.68x-9.53x-25.55x-16.83x6.96x8.35x-604.70x-176.41x-30.48x-16.33x-8.47x-32.79x-19.22x-13.23x-12.13x-46.65x
Total Equity70.09M74.38M87.17M99.29M106.54M99.17M49.88M28.54M25.61M27.17M28.11M31.03M26.83M28.9M35.73M38.65M38.9M35.92M42.21M51.76M59.71M63.24M63.66M15.13M7.44M162.62K7.37M
Equity Growth %-41.69%-14.68%-12.2%-6.8%7.43%98.82%74.76%11.43%-5.74%-3.32%-9.41%15.65%-7.17%-19.11%-7.56%-0.64%8.3%-14.89%-18.46%-13.31%-5.57%-0.67%320.65%103.5%4473.23%-97.79%-
Book Value per Share2.342.482.913.323.232.901.500.870.780.850.961.050.981.071.361.471.481.511.772.182.532.712.500.620.370.010.38
Total Shareholders' Equity70.09M74.38M87.17M99.29M106.54M99.17M49.88M28.54M25.61M27.17M28.11M31.03M26.83M28.9M35.73M38.65M38.9M35.92M42.21M51.76M59.71M63.24M63.66M15.13M7.44M162.62K7.37M
Common Stock000000000000000000000000037.67M36.77M
Retained Earnings9.59M13.87M26.67M38.79M46.03M41.18M-9.67M-33.89M-37.04M-35.7M-31.96M-28.02M-32.34M-29.98M-23.77M-19.63M-21.05M-23.45M-14.03M-4.39M2.56M6.43M7.67M-39.9M-47.35M-40.53M-33.31M
Treasury Stock-12.89M-12.89M-12.89M-12.89M-12.89M-5.27M000000-1.1M-1.1M-122.2K000000000000
Accumulated OCI00000000-24.67M-23.78M-22.95M-22.09M-21.24M-20.17M-18.98M-17.72M-16.45M-14.99M-13.63M-12.28M-10.91M-9.53M-8.23M-6.97M-5.71M-4.43M-3.29M
Minority Interest000000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and operational insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Erosion Signals Distress

As reported in recent financial filings, RVP's total assets have contracted from $179.7M in 2023Q4 to $137.6M in 2026Q1, reflecting a consistent downward trend that suggests the company is liquidating its balance sheet to fund ongoing operational losses rather than investing in future growth.

The steady decline in total assets, coupled with the erosion of retained earnings, points to a business model that is currently consuming its own capital base. Investors should monitor whether this trajectory leads to a critical breach of liquidity thresholds as the asset base continues to shrink.

Fixed Asset Concentration Risks Liquidity

Based on the provided quarterly data, net PPE accounts for approximately 56% of total assets as of 2026Q1, indicating an asset-heavy manufacturing model that lacks the flexibility to pivot away from its current high-cost, low-margin production environment in Little Elm, Texas.

The high concentration of capital in specialized manufacturing equipment may represent a significant impairment risk if the company cannot achieve the utilization rates necessary to justify these assets. This lack of asset liquidity limits the firm's ability to raise non-dilutive capital during periods of operational stress.

Cash Runway Nearing Critical Levels

According to the latest balance sheet, cash and equivalents have dwindled to $2.8M as of 2026Q1, a sharp decline from the $12.7M reported in 2023Q4, which suggests the company's buffer against operational shocks is rapidly evaporating in the face of persistent negative cash flow.

While the current ratio remains elevated at 5.74, this metric is likely distorted by the composition of current assets, which may include slow-moving inventory that is difficult to convert to cash. The rapid depletion of liquid reserves warrants immediate investigation into the company's near-term funding requirements.

Retained Earnings Decline Reflects Losses

As indicated by historical balance sheet data, retained earnings have fallen from $38.8M in 2023Q4 to $9.6M in 2026Q1, illustrating the cumulative impact of sustained operating losses on the company's equity quality and overall financial health.

The consistent reduction in retained earnings suggests that the company is effectively returning no value to shareholders and is instead depleting its equity base to cover operating deficits. This trend may indicate that the current business model is not self-sustaining without external capital injections.

Inventory Obsolescence Risk Remains Hidden

Based on the provided financial statements, the absence of significant goodwill or intangible assets is notable, yet the reliance on physical inventory in a rapidly evolving medical device market suggests a potential for hidden write-downs that could further impair the company's already fragile equity position.

Investors should be cautious of the valuation of inventory on the balance sheet, as any shift in clinical standards could render existing stock obsolete. The lack of transparency regarding inventory aging makes it difficult to assess the true realizable value of the company's current asset base.

RVP — Frequently Asked Questions

Quick answers to the most common questions about buying RVP stock.

What are the total assets of Retractable Technologies, Inc. (RVP)?

As of 2025, Retractable Technologies, Inc. (RVP) had total assets of $142.6M including $63.1M in current assets.

How much debt does Retractable Technologies, Inc. (RVP) have?

Retractable Technologies, Inc. (RVP) carries total debt of $0.9M, offset by $37.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Retractable Technologies, Inc.?

Retractable Technologies, Inc. (RVP) has total shareholders' equity (book value) of $74.4M ($2.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Retractable Technologies, Inc.'s current ratio and liquidity?

Retractable Technologies, Inc. (RVP) reported a current ratio of 6.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.